Digest Network Come funziona
Network
/
Società
HA
Non verificato

HAYA Therapeutics, SA

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaMedicina - VarieSalute

5 comunicati stampa

Guarda tutti i comunicati
08/05/2025
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Oncologia
HAYA Therapeutics Raises $65 Million in Series A Funding to Deliver Precision RNA-Guided Medicines for Chronic and Age-Related Diseases
Fonte
HAYA Therapeutics, SA
Emittente
Business Wire
1.00
0
02/05/2025
Eventi
Scienza
Igiene alimentare
Biotecnologia
Salute
Medicina - Varie
Cardiologia
Farmaceutica
HAYA Therapeutics to Present on RNA-Guided Regulatory Genome Platform at the Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Fonte
HAYA Therapeutics, SA
Emittente
Business Wire
1.00
0
12/02/2025
Biotecnologia
Igiene alimentare
Medicina alternativa
Salute
Sanità
Oncologia
Scienza
Medicina - Varie
Cardiologia
Eventi
HAYA Therapeutics Awarded Innosuisse Certificate for Sustainable Growth and Funding to Advance Treatment for Aggressive Solid Tumors
Fonte
HAYA Therapeutics, SA
Emittente
Business Wire
1.00
0
04/09/2024
Mercato del lavoro
Industria
Biotecnologia
Farmaceutica
Salute
HAYA Therapeutics Announces Collaboration with Lilly to Discover Novel Regulatory Genome Targets for Obesity and Related Metabolic Conditions Using Proprietary RNA Platform
Fonte
HAYA Therapeutics, SA
Emittente
Business Wire
1.00
0
18/07/2024
HAYA Therapeutics Appoints Former Roche Global Head of Operations Eric Adam, Ph.D. as Chief Operating Officer
Fonte
HAYA Therapeutics, SA
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0